Showing results (241-250 of 2,409) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|February 7, 2019
The burden of illness of hepatorenal syndrome (HRS) in the United States: a retrospective analysis of electronic health recordsKhurram Jamil, Xingyue Huang, Belinda Lovelace, et al.Journal of Medical Economics|February 8, 2019
The impact of copay assistance on patient out-of-pocket costs and treatment rates with ALK inhibitorsArpamas Seetasith, William Wong, Jenny Tse, et al.Journal of Medical Economics|February 10, 2019
The association between the severity of chronic kidney disease and medical costs among patients with type 2 diabetesMaureen J Lage, Kristina S Boye, Jay Patrick Bae, et al.Journal of Medical Economics|February 13, 2019
Time-driven activity-based cost analysis for outpatient anticoagulation therapy: direct costs in a primary care setting with optimal performanceRohit A Bobade, Richard A Helmers, Thomas M Jaeger, et al.Journal of Medical Economics|January 22, 2019
Cost-effectiveness analysis of dapagliflozin treatment versus metformin treatment in Chinese population with type 2 diabetesXiaoling Cai, Lizheng Shi, Wenjia Yang, et al.Journal of Medical Economics|March 15, 2018
Disease-related expenditures and revision rates in chronic rhinosinusitis patients after endoscopic sinus surgeryTina D Hunter, Adam S DeConde, R Peter ManesJournal of Medical Economics|November 29, 2018
Cost-utility analysis of levodopa carbidopa intestinal gel (Duodopa) in the treatment of advanced Parkinson's disease in patients in Scotland and WalesSvetlana Kalabina, Jonathan Belsey, Dominic Pivonka, et al.Journal of Medical Economics|January 24, 2020
Cost-effectiveness of mirogabalin for the treatment of post-herpetic neuralgia in TaiwanXin Ye, Emma Gray, Yen-Feng Wang, et al.Journal of Medical Economics|January 18, 2020
Cost-effectiveness of atezolizumab versus docetaxel and nivolumab in the treatment of non-small cell lung cancer as a second line in FranceSivignon Marine, Roze Stéphane, Plommet Nicolas, et al.Journal of Medical Economics|October 31, 2019
Association of antipsychotic treatment switching in patients with schizophrenia, bipolar, and major depressive disordersRajeev Ayyagari, Darren Thomason, Fan Mu, et al.Pageof 241